spacer spacer  
  spacer
 
underline
spacer


Sponsored by:

pim-logo
www.pimed.com

This activity is supported by an educational grant from

merck logo

banner
 
underline
spacer
 
  • Salt Lake City, UT - (Sep 9, 2008)
  • Seattle, WA - (Sep 10, 2008)
  • Palo Alto, CA - (Sep 11, 2008)
  • Cincinnati, OH - (Sep 16, 2008)
  • Philadelphia, PA - (Sep 17, 2008)
  • Minneapolis, MN - (Sep 18, 2008)
  • Boston, MA - (Sep 25, 2008)
  • Baltimore, MD - (Sep 29, 2008)
  • Durham, NC - (Sep 30, 2008)
  • Memphis, TN - (Oct 1, 2008)
  • Dallas, TX - (Oct 2, 2008)
  • San Juan, PR - (Oct 29, 2008)
  • Coral Gables, FL - (Oct 30, 2008)
  •  
    underline
    spacer
     

    Nosocomial (hospital-acquired) bloodstream infections continue to complicate the clinical course of critically ill patients and, consequently, to create substantial economic and human costs. These infections may lead to complications in approximately 30% of those patients admitted to an intensive care unit (ICU) and cost an estimated $25,000 per infection. Previous studies have shown that the administration of inadequate antimicrobial treatment of bloodstream infections is associated with a significantly higher mortality rate; therefore, strategies to limit bloodstream infections in the ICU have been developed to improve patient outcomes. Although healthcare providers are cognizant of measures to control infection, inconsistent application of these measures remains a concern in the ICU.

    In this regional dinner meeting series, we will present up-to-date information on the risk of acquiring nosocomial fungal infections, highlight the most common sites of these infections, and discuss strategies for preventing and controlling bloodstream infections. The goals are to enhance the awareness and understanding of the risks for bloodstream infections and encourage consistent application of infection control measures to promote more favorable outcomes for patients.

     
    underline
    spacer
     
    George Karam, MD (Chair)
    Louisiana State University School of Medicine
    New Orleans, LA
    Marin H. Kollef, MD
    Washington University School of Medicine
    St. Louis, MO
    spacer
    Ethan G. Leonard, MD
    Rainbow Babies & Children’s Hospital
    Cleveland, OH
    Carla M. Odio, MD
    University of Costa Rica
    San Jose, Costa Rica
     
    underline
    spacer
     

    6:00 - 6:30 PM Registration and Dinner

    6:30 - 6:35 PM Introduction and Overview
    Local Moderator

    6:35 - 7:00 PM Principles in Antimicrobial Therapy in the Era of Antibiotic Stewardship
    Marin H. Kollef, MD

    7:00 - 7:25 PM Antifungal Therapy for Neonatal Fungemia
    Ethan G. Leonard, MD, or Carla M. Odio, MD

    7:25 - 7:55 PM Question and Answer Session

    7:55 - 8:00 PM Program Conclusion
    Local Moderator

    Note: All times listed are in local time.

     
    underline
    spacer
      After completing this activity, the participant should be better able to:
    • Identify patients at risk for bloodstream infections and multiple drug-resistant pathogens.
    • Outline approaches to the prevention and treatment of bacterial and pediatric fungal infections.
    • Explain issues with adequate empiric therapy, including the morbidity/mortality associated with inadequate treatment.
    • Describe de-escalation therapy, including its implementation into clinical practice.
    • Identify issues that influence antibiotic stewardship.
     
    underline
    spacer
     

    Intended Audience
    Infectious disease physicians, hospitalists, internal medicine physicians, critical care and intensive care physicians; infectious disease, critical care, and ICU nurses; fellows (surgical and medical); and hospital pharmacists, ICU pharmacists, and hospital formulary committee directors.

    Physician Continuing Medical Education
    Accreditation Statement
    This activity has been planned and implemented in accordance with the Essential Areas and Policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint sponsorship of Postgraduate Institute for Medicine (PIM) and Advanced Studies in Medicine (ASiM). PIM is accredited by the ACCME to provide continuing medical education for physicians.

    Credit Designation
    Postgraduate Institute for Medicine designates this educational activity for a maximum of 1.5 AMA PRA Category 1 Credit(s)™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

     
    Pharmacist Continuing Education
    acpe logo Accreditation Statement
    Postgraduate Institute for Medicine is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.
     


    Credit Designation
    Postgraduate Institute for Medicine (PIM) designates this continuing education activity for 1.5 contact hour(s) (0.15 CEUs) of the Accreditation Council for Pharmacy Education.
    (Universal Program Number – 809-999-08-186-L01-P.)

    Disclosure of Conflicts of Interest
    Postgraduate Institute for Medicine (PIM) assesses conflict of interest with its instructors, planners, managers and other individuals who are in a position to control the content of CME activities. All relevant conflicts of interest that are identified are thoroughly vetted by PIM for fair balance, scientific objectivity of studies utilized in this activity, and patient care recommendations. PIM is committed to providing its learners with high quality CME activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of a commercial interest.

    Fee Information
    There is no fee for this educational activity. A statement of credit will be issued only upon receipt of a completed activity evaluation form and will be mailed to you within 3 weeks.

     
    spacer  
      spacer
    Advanced Studies in Medicine © 2008 Contact Us
    spacer  
    spacer